Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.94 USD | -3.25% | +11.22% | +176.16% |
May. 15 | Needham Adjusts Price Target on Arcutis Biotherapeutics to $18 From $16, Maintains Buy Rating | MT |
May. 15 | Sector Update: Health Care Stocks Rise Pre-Bell Wednesday | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+176.16% | 1.07B | |
+7.25% | 113B | |
+11.00% | 106B | |
+1.02% | 22.27B | |
-12.23% | 22.22B | |
-5.71% | 19.43B | |
-37.85% | 17.87B | |
-5.97% | 17.24B | |
+7.39% | 14.29B | |
+34.90% | 12.52B |
- Stock Market
- Equities
- ARQT Stock
- News Arcutis Biotherapeutics, Inc.
- Transcript : Arcutis Biotherapeutics, Inc., Q1 2023 Earnings Call, May 09, 2023